EFFICACY AND SAFETY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 4 YEARS: FINAL RESULTS FROM THE UNIFI LONG-TERM EXTENSION

Waqqas Afif  1     Maria T. Abreu  2     Silvio Danese  3     William Sandborn  4     Ye Miao  5     Hongyan Zhang  5     Remo Panaccione  6     Tadakazu Hisamatsu  7     Ellen J. Scherl  8     Rupert W Leong  9     David Rowbotham  10     Ramesh P. Arasaradnam  11     Laurent Peyrin-Biroulet  12     Bruce E. Sands  13     Colleen W. Marano  13    
1 McGill University Health Center, Montreal, Canada
2 University of Miami, Miller School of Medicine, Miami, United States
3 Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Milan, Italy
4 University of California San Diego, San Diego, United States
5 Janssen Research & Development, LLC, Spring House
6 University of Calgary, Calgary, Canada
7 Kyorin University School of Medicine, Tokyo, Japan
8 Weill Cornell Medicine, New York Presbyterian Hospital, New York, United States
9 Concord Hospital, Sydney, Australia
10 Auckland City Hospital, Auckland, New Zealand
11 University Hospital Coventry and Warwickshire, Coventry Warwickshire, United Kingdom
12 Nancy University Hospital, Vandoeuvre-les-Nancy, France
13 Icahn School of Medicine at Mount Sinai, New York, United States

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing